Skip to content
CancerIndex

Publication

Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).

Authors not recorded

Rare Dis2014PMID 26942101PMC4755243stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (2)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 2

Curated evidence

Evidence citing this paper (1)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
26942101
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–1 of 1 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
SMARCA4 INACTIVATING MUTATION1
(diagnostic)Small-cell Carcinoma Of The Ovary Of Hypercalcemic TypeUNRESOLVEDDiagnosticBSupports Positive3accepted
EID8065

Performed Sanger sequencing and immunohistochemistry of SMARCA4 in 12 SCCOHT (Small cell carcinoma of the ovary, hypercalcemic type) tumors. When complementing this data with data previous data from o… (full text at CIViC)

PMID 26942101 · Ramos et al., 2014 · Open in CIViC

civic